PepGen Inc.

PepGen Inc. Stock Forecast & Price Prediction

Live PepGen Inc. Stock (PEPG) Price
$8.97

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$8.97

P/E Ratio

-2.80

Volume Traded Today

$91,799

Dividend

$0.42

52 Week High/low

19.30/3.72

PepGen Inc. Market Cap

$301.5M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $PEPG ๐Ÿ›‘

Before you buy PEPG you'll want to see this list of ten stocks that have huge potential. Want to see if PEPG made the cut? Enter your email below

PEPG Summary

Based on ratings from 0 stock analysts, the PepGen Inc. stock price is expected to increase by 118.51% in 12 months. This is calculated by using the average 12-month stock price forecast for PepGen Inc.. The lowest target is $10 and the highest is $26. Please note analyst price targets are not guaranteed and could be missed completely.

PEPG Analyst Ratings

PepGen Inc. has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that PepGen Inc. will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

PEPG stock forecast by analyst

These are the latest 20 analyst ratings of PEPG.

Analyst/Firm

Rating

Price Target

Change

Date

Andrew Fein
HC Wainwright & Co.

Buy

$26

Reiterates

Aug 1, 2024
Laura Chico
Wedbush

Outperform

$20

Reiterates

Jul 31, 2024
Laura Chico
Wedbush

Outperform

$20

Reiterates

May 15, 2024
Andrew Fein
HC Wainwright & Co.

Buy

$26

Reiterates

May 15, 2024
Laura Chico
Wedbush

Outperform

$20

Maintains

Mar 7, 2024
Laura Chico
Wedbush

Outperform

$21

Reiterates

Jan 30, 2024
Andrew Fein
HC Wainwright & Co.

Buy

$26

Reiterates

Sep 7, 2023

HC Wainwright & Co.

Buy


Reiterates

Aug 9, 2023
Paul Matteis
Stifel

Buy

$24

Reiterates

Jun 14, 2023
Laura Chico
Wedbush

Outperform

$22

Reiterates

Jun 14, 2023
Laura Chico
Wedbush

Outperform

$22

Reiterates

May 31, 2023
Andrew Fein
HC Wainwright & Co.

Buy

$26

Reiterates

May 12, 2023
Andrew Fein
HC Wainwright & Co.

Buy

$26

Reiterates

Apr 3, 2023
Andrew Fein
HC Wainwright & Co.

Buy

$26

Reiterates

Mar 24, 2023
Laura Chico
Wedbush

Outperform

$22

Maintains

Mar 24, 2023
Andrew Fein
HC Wainwright & Co.

Buy

$26

Initiates

Dec 21, 2022
Joseph Schwartz
SVB Leerink

Outperform

$33

Maintains

Nov 10, 2022
Tazeen Ahmad
B of A Securities

Buy

$16

Initiates

May 31, 2022
Paul Matteis
Stifel

Buy

$24

Initiates

May 31, 2022
Joseph Schwartz
SVB Leerink

Outperform

$40

Initiates

May 31, 2022

PEPG Company Information

  • Company Name: PepGen Inc.
  • Type: Clinical-stage biotechnology company
  • Focus: Development of oligonucleotide therapeutics
  • Treatment Areas: Severe neuromuscular and neurologic diseases
  • Lead Product Candidate: PGN-EDO51
  • Current Trial Phase: Phase 2 clinical trial for Duchenne muscular dystrophy (DMD)
  • Other Product Candidates:
    • PGN-EDODM1 - Phase 1 trial for myotonic dystrophy type 1
    • PGN-EDO53
    • PGN-EDO45
    • PGN-EDO44
  • Founded: 2018
  • Location: Boston, Massachusetts
PEPG
PepGen Inc. (PEPG)

When did it IPO

2022

Staff Count

72

Country

United States

Sector/Industry

Healthcare/Biotechnology

CEO

Dr. James G. McArthur Ph.D.

Market Cap

$301.5M

PepGen Inc. (PEPG) Financial Data

In 2023, PEPG generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that PEPG's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

$0

Revenue From 2021

$0

0.00 %
From Previous Year

Revenue From 2022

$0

0.00 %
From Previous Year

Revenue From 2023

$0

0.00 %
From Previous Year
  • Revenue TTM $0
  • Operating Margin TTM 0.0%
  • Gross profit TTM $0
  • Return on assets TTM -31.9%
  • Return on equity TTM -59.0%
  • Profit Margin 0.0%
  • Book Value Per Share 4.76%
  • Market capitalisation $301.5M
  • Revenue for 2021 $0
  • Revenue for 2022 $0
  • Revenue for 2023 $0
  • EPS this year (TTM) $-3.31

PepGen Inc. (PEPG) Latest News

No news data available.

...

PEPG Frequently asked questions

The highest forecasted price for PEPG is $26 from Andrew Fein at HC Wainwright & Co..

The lowest forecasted price for PEPG is $10 from from

The PEPG analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.